Subacture Thyroiditis During Interferon Therapy

A 34-year-old woman with chronic hepatitis C received interferon- alpha (IFN-alpha) therapy. Her thyroid function was normal and thyroid autoantibodies were negative before treatment, Four months after the beginning of the therapy she presented a clinical course of thyroiditis with a transient thyrotoxicosis. The diagnosis of subacute thyroiditis was confirmed by laboratory, ultrasonography, radioiodine scanning and fine needle aspiration findings. Thyroid autoantibodies were persisting negative. She suspended IFN-alpha therapy and she started non steroidal anti-inflammatory agents and beta-blockers. Latent hypothyroidism subsequently developed, but L- thyroxine therapy resulted in a rapid normalization of thyroid function tests. (C) 1997, Editrice Kurtis.

Author: FALASCHI P, UNIV ROMA LA SAPIENZA, CATTEDRA CLIN MED 1, V POLICLIN 155, I-00161 ROME, ITALY Source: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 1997 JAN;20(1):24-28

15 Tips for Managing Interferon-Ribavirin Side Effects
Finding new ways to manage the side effects of Hepatitis C combination therapy adds to a person’s likelihood of conquering the virus....

New Mexico Offers Free Hepatitis C Hotline
Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about...

Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...